Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.
about
Cyclooxygenase-2 and the inflammogenesis of breast cancer.Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice.Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaEvaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasiaDNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.Expression of COX-2, CD44v6 and CD147 and relationship with invasion and lymph node metastasis in hypopharyngeal squamous cell carcinoma.p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia.Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues.Progression of Ductal Carcinoma in Situ from the Pathological Perspective.Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.Assessment of the accuracy of the Gail model in women with atypical hyperplasia.The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs.Sclerosing adenosis and risk of breast cancer.Immune cell quantitation in normal breast tissue lobules with and without lobulitis.Physiological COX-2 expression in breast epithelium associates with COX-2 levels in ductal carcinoma in situ and invasive breast cancer in young womenNanoString-based breast cancer risk prediction for women with sclerosing adenosis.COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness.Molecular profile of atypical hyperplasia of the breast.
P2860
Q30367680-145D8D8E-7071-44CE-9AE4-503083F6A85AQ33690748-E29048F2-F05F-4FDD-9EA2-D0E03235B6F9Q33932379-FC7AF31A-294A-4BD9-ABA7-59E0224F54C3Q34049245-A59A40E2-9361-4F67-91D3-812A3296F3E2Q34194526-E910C186-2504-4B28-B9C1-5EC0B96618A9Q34206453-37EC152E-38EC-4FC7-8584-1AD4905031BCQ34982652-C529DDE5-B686-4244-91AF-78EF1AC96A53Q35597120-4C42B03D-2EC2-40E8-AE7F-0BA380743D51Q35624148-33D75A60-2042-40EC-BA23-3A9629E6A193Q35940085-53DD7638-D49F-4847-BCE8-FAA3E4156AE4Q37097204-DE234CA2-A7F6-42F8-B6DF-5BECCED3E2D7Q37117079-91306CD0-77DB-45F3-8751-BC2EEE68D1C5Q37372902-C05A9C08-D75F-468B-A425-3CDDEC57E8F7Q37583096-0F9D62AD-4BC4-42CC-BE86-AB331E506770Q37656390-740FDEB1-402D-4303-AF70-11ADD44C0C3FQ37672896-11CE9C3E-209D-4AF5-B249-FD2B1CA003E0Q38629398-98145796-7568-4882-8BCD-A45B812C1C4BQ39138862-88C72C8B-27EC-4C0C-8697-BB8CD1BCA3B5Q47947859-ABBF9280-C260-4C35-BC8D-4A689D61D24F
P2860
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Association between cyclooxyge ...... sia and risk of breast cancer.
@en
type
label
Association between cyclooxyge ...... sia and risk of breast cancer.
@en
prefLabel
Association between cyclooxyge ...... sia and risk of breast cancer.
@en
P2093
P2860
P356
P1476
Association between cyclooxyge ...... sia and risk of breast cancer.
@en
P2093
Ari Ristimäki
Carol Reynolds
Daniel W Visscher
Lynn C Hartmann
Marlene H Frost
Marta Santisteban
Robert A Vierkant
V Shane Pankratz
Wilma L Lingle
P2860
P304
P356
10.1093/JNCI/DJN036
P407
P577
2008-03-11T00:00:00Z